Dr John Melki, CEO Genetic Signatures, will be presenting on 3base™  the Science behind EasyScreen™ Molecular Diagnostic Assays at the upcoming Molecular Microbiology Meeting (MMM 2014). MMM2014 will be held on 5-6 March at WatervieW in Bicentennial Park, Sydney, NSW, Australia and provides a forum for research scientists, laboratory staff and clinicians to share the latest…

Genetic Signatures is in the final stages of clinical validation of an expanded target offering for the EasyScreen™ Enteric Bacterial detection panel. The new optional multiplex real-time PCR mix C will include targets for Aeromonas hydrophila, Vibrio cholerae/Vibrio parahaemolyticus, and Shiga Toxigenic E. coli (stx1/stx2). This will increase the number of targets in the EasyScreen™ Enteric Bacterial Detection…

Genetic Signatures will be exhibiting at The Australian Society for Microbiology, Annual Scientific Meeting, from 7 – 10 July 2013 in Adelaide, Australia. Genetic Signatures will showcase the latest products in their EasyScreen range for the detection of infectious disease including kits for diagnosing bacterial, viral and protazoan causes of gastroenteritis, including toxigenic and hypervirulent C. difficile, direct…

Genetic Signatures will increase its European Market presence at the 23rd European Congress of Clinical Microbiology and Infectious Diseases, which will be held in Berlin from 27 to 30 April 2013. Genetic Signatures will showcase the latest products in their EasyScreen range for the detection of infectious disease including kits for diagnosing bacterial, viral and protazoan causes of…

The Molecular Microbiology Meeting 2013 (MMM2013) will be held on 6-7 March at WatervieW in Bicentennial Park, Sydney NSW Australia. MMM provides a forum for research scientists, laboratory staff and clinicians to share the latest issues and developments in the field of molecular microbiology. Genetic Signatures will showcase the latest products in their EasyScreen range for the detection…

Following on from the CE-IVD approval of the EasyScreen™ C. difficile kits Genetic Signatures has received the CE mark for it’s EasyScreen™ Enteric Protozoan Detection Kit. The EasyScreen™ Protozoan Detection Kit is a real-time PCR kit for the detection of Entamoeba, Dientamoeba, Cryptosporidium, Giardia and Blastocystis. The multiplexed real-time PCR is performed over two wells and includes an…

Genetic Signatures is pleased to announce that it has gained the European CE-IVD Mark for its EasyScreen™ C. difficile Reflex Kit. The real-time multiplex PCR assay can be used directly from patient stool samples and yields a result in approximately 3 hours. The EasyScreen™ C. difficile Reflex kit detects the more dangerous hypervirulent forms of…

Genetic Signatures will be presenting a poster and exhibiting at ASM 2012 in Brisbane from 1- 4 July 2012. The poster presented by S.P. Siah and K. Kaur (Research Scientists Genetic Signatures) will describe the development of a complete screening system for the diagnosis of all major gastrointestinal pathogens from primary clinical samples. The EasyScreen assays…

  Genetic Signatures has launched a new EasyScreen™ product range at the 22nd European Congress of Clinical Microbiology and Infectious Diseases in London from 31st March to 3rd April 2012. The range includes kits for diagnosing bacterial, viral and protazoan causes of gastroenteritis direct from faeces. Dr John Melki has presented a poster outlining the…

Genetic Signatures is pleased to announce the launch of EasyScreen kits for the detection of Enteric Pathogens. The range includes kits for diagnosing bacterial, viral and protazoan causes of gastroenteritis direct from faeces. A universal sample preparation method allows for rapid efficient (automatable) nucleic acid isolation. Existing nucleic acid isolation and real-time PCR platforms can be utilized,…